US Patent Issued to MEDIVIS on Aug. 19 for "Chemically and physically stable topical ophthalmic nepafenac-based formulations" (Italian Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,429, issued on Aug. 19, was assigned to MEDIVIS S.R.L. (Tremestieri Etneo, Italy).

"Chemically and physically stable topical ophthalmic nepafenac-based formulations" was invented by Danilo Aleo (Tremestieri Etneo, Italy), Maria Grazia Saita (Tremestieri Etneo, Italy), Barbara Melilli (Tremestieri Etneo, Italy), Sergio Mangiafico (Tremestieri Etneo, Italy) and Melina Cro (Tremestieri Etneo, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Topical ophthalmic Nepafenac-based formulations, which are particularly stable from both chemical and physical points of view, are provided."

The patent was filed on Jan. 14, 2020, under Application No. 17/422,...